Cambodia vs Eritrea: Prevalence rate of hypertension in adults aged 30-79
Cambodia
25.7
in 2019
Eritrea
23.7
in 2019
Cambodia rank
190th
Eritrea rank
191st
Prevalence rate of hypertension in adults aged 30-79 over time
- Cambodia
- Eritrea
How they compare
Cambodia currently reports 25.7 against 23.7 in Eritrea, a difference of 2.
That makes Cambodia's figure about 1.1 times Eritrea's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Eritrea ahead.
Cambodia ranks 190th and Eritrea ranks 191st of 194 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Eritrea in 2.
Head to head by decade
| Decade | Cambodia | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.84 | 25.4 | 2.56 | Eritrea |
| 2000s | 23.3 | 25.05 | 1.75 | Eritrea |
| 2010s | 24.64 | 24.34 | 0.3 | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Cambodia or Eritrea?
- Cambodia, at 25.7 against 23.7 in Eritrea as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Cambodia and Eritrea?
- 2, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Eritrea?
- 30 years are reported by both, from 1990 to 2019.
- How do Cambodia and Eritrea rank globally for prevalence rate of hypertension in adults aged 30-79?
- Cambodia ranks 190th and Eritrea ranks 191st of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.